色噜噜人体337p人体 I 超碰97观看 I 91久久香蕉国产日韩欧美9色 I 色婷婷我要去我去也 I 日本午夜a I 国产av高清怡春院 I 桃色精品 I 91香蕉国产 I 另类小说第一页 I 日操夜夜操 I 久久性色 I 日韩欧在线 I 国产深夜在线观看 I 免费的av I 18在线观看视频 I 他也色在线视频 I 亚洲熟女中文字幕男人总站 I 亚洲国产综合精品中文第一 I 人妻丰满熟av无码区hd I 新黄色网址 I 国产精品真实灌醉女在线播放 I 欧美巨大荫蒂茸毛毛人妖 I 国产一区欧美 I 欧洲亚洲1卡二卡三卡2021 I 国产亚洲欧美在线观看三区 I 97精品无人区乱码在线观看 I 欧美妇人 I 96精品在线视频 I 国产人免费视频在线观看 I 91麻豆国产福利在线观看

雅思閱讀模擬試題參考

時間:2021-06-10 19:14:49 試題 我要投稿

雅思閱讀模擬試題參考

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

雅思閱讀模擬試題參考

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock.

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

  Under pressure

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap.

  Going up

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

  (613 words nature)

  Questions 1-7

  This passage has 7 paragraphs 1-7.

  Choose the correct heading for each paragraph from the list of headings below.

  Write the correct number i-ix in boxes 1-7 on your answer sheet.

  List of Headings

  i. How does torcetrapib work?

  ii. Contradictory result prior to the current trial

  iii. One failure may possibly bring about future success

  iv. The failure doesn’t lead to total loss of confidence

  v. It is the right route to follow

  vi. Why it’s stopped

  vii. They may combine and theoretically produce ideal result

  viii. What’s wrong with the drug

  ix. It might be wrong at the first place

  Example answer

  Paragraph 1 iv

  1. Paragraph 2

  2. Paragraph 3

  3. Paragraph 4

  4. Paragraph 5

  5. Paragraph 6

  6. Paragraph 7

  Questions 7-13

  Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。

  Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

  NB You may use any letter more than once.

  7.It has been administered to over 10,000 subjects in a clinical trial.

  8.It could help rid human body of cholesterol.

  9.Researchers are yet to find more about it.

  10. It was used to reduce the level of cholesterol.

  11. According to Kashyap, it might lead to unwanted result if it’s blocked.

  12. It produced contradictory results in different trials.

  13. It could inhibit LDLs.

  List of choices

  A. Torcetrapic

  B. HDLS

  C. Statin

  D. CETP

  (by Zhou Hong)

  Suggested Answers and Explanations

  1. vi

  2. ii

  3. vii 本段介紹了torcetrapib和statin的治病原理,但是同時短語in contrast與之前第二段后半段的內容呼應,暗示了這兩種藥在理論上能相輔相成,是理想的搭配。第一個選項無法涵蓋整段意義,故選擇i是錯誤的。

  4. iii 本段分析了可能導致torcetrapibl臨床試驗失敗的原因,后半段指出如果以上推測正確,那么未來的藥物可借鑒這個試驗,設法避免torcetrapib的缺陷,研制出有效的'藥物。viii選項無法涵蓋后半段的意思。

  5. ix 見首句。

  6. v

  7. A 見第二段。題目中administer一詞意為用藥,subject一詞為實驗對象之意。

  8. B 見第四段… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.即HDLs的作用最終是將 choleserol清除出人體:… for removal from the body。

  9. B 見第四段But HDLs are complex and not entirely understood.

  10. C 見第二段… plus a cholesterol-lowering statin,即statin是可以降低cholesterol的。

  11. D 見第六段 So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

  12. A 見第三段。

  13. C 見第四段Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

【雅思閱讀模擬試題參考】相關文章:

雅思歷年閱讀模擬試題04-01

雅思閱讀模擬練習試題及答案11-26

雅思模擬閱讀習題06-14

雅思聽力模擬試題練習03-19

科學模擬試題參考06-11

模擬試題及答案參考06-13

雅思閱讀模擬練習題06-14

雅思閱讀經典模擬題06-13

關于雅思閱讀模擬習題及答案12-27

主站蜘蛛池模板: 午夜剧场18 | 午夜福利毛片 | 成人在线观看一区 | 噜噜噜噜噜久久久久久91黄画 | 国产手机精品a | 吊视频一区二区三区 | 欧美黑人性暴力猛交喷水黑人巨大 | 欧美精品一二三区 | 中国黄色一级毛片 | 免费无码av片在线观看网址 | 国产视频69 | 护士奶头又白又大又好摸视频 | 欧美另类在线观看 | 探花精品 | 成人毛片视频在线播放 | 成人在线观看黄色 | 欧美激情一级欧美精品 | 麻豆国产丝袜白领秘书在线观看 | 日韩精品视频在线 | 三级毛片在线播放 | 国产白丝无码免费视频 | 狠狠色综合激情丁香五月 | 国产最新精品视频 | 亚洲欧美日韩国产综合精品二区 | 日韩中文字幕网 | 蜜桃臀av高潮无码 | 久久99日韩 | 久久国产劲爆∧v内射 | 日韩女同在线 | 艳妇荡乳豪妇荡乳av精东 | 777午夜精品免费观看 | 99ri国产在线 | 好吊妞国产欧美日韩免费观看网站 | 日韩成人在线视频观看 | 天堂资源网在线 | 午夜一区二区国产好的精华液 | 亚洲免费永久精品国产 | 三级网站在线播放 | 精品人妻无码一区二区三区性 | 国产边摸边吃奶边叫做激情视频 | 色丁香在线 | 欧美情趣视频 | 91精品国模一区二区三区 | 东京热无码一区二区三区分类视频 | 懂色一区二区三区久久久 | 一本色综合亚洲精品 | 免费一级毛片在线观看 | 哪个网站可以看毛片 | 国产乱码1卡二卡3卡四卡5 | 男人操女人下面 | 一级做a爱 | 99精品国产一区二区三区a片 | 人人添人人爽 | 各类熟女熟妇真实视频 | 国产成人亚洲日韩欧美 | 婷婷丁香六月 | 精品国产第一国产综合精品 | 国产一区二区视频播放 | 久久好在线视频 | 黄色视屏在线免费观看 | 午夜在线视频一区二区区别 | 国产精品精品国产 | 韩国色网 | 美女又爽又黄网站视频 | 女人张开双腿让男人猛桶 | 人妻少妇88久久中文字幕 | 亚洲精品无码不卡在线播he | 8ⅹ8x擦拨擦拨成人免费视频 | 久久综合狠狠综合久久综 | 久久久免费观看 | 精品免费国产一区二区三区四区介绍 | 国语粗话呻吟对白视频 | 婷婷深爱 | 无码精品视频一区二区三区 | 88欧产日产国产精品 | 久久精品国产69国产精品亚洲 | 免费人成又黄又爽的视频 | 国产成人综合色在线观看网站 | 日日日日日 | 日本一区不卡在线观看 | 日本久久久久久久久久加勒比 | 少妇性荡欲午夜性开放视频剧场 | 国产很色很黄很大爽的视频 | 亚洲激情a | 国产夜色精品一区二区av | 97超碰国产精品无码分类 | 18禁无遮拦无码国产在线播放 | 爱情岛论坛成人 | 亚洲处破女av一区二区中文 | 欧美老熟妇乱子伦视频 | 国产色妇 | 亚洲gv天堂无码男同在线观看 | 日韩爱爱视频 | 91久久香蕉国产日韩欧美9色 | 91手机视频在线观看 | 88国产精品欧美一区二区三区 | 先锋影音一区二区三区 | 求一个黄色网址 | 男人添女人囗交图 |